centa has been researched along with pyridine-2-azo-4-dimethylaniline cephalosporin in 1 studies
| Studies (centa) | Trials (centa) | Recent Studies (post-2010) (centa) | Studies (pyridine-2-azo-4-dimethylaniline cephalosporin) | Trials (pyridine-2-azo-4-dimethylaniline cephalosporin) | Recent Studies (post-2010) (pyridine-2-azo-4-dimethylaniline cephalosporin) |
|---|---|---|---|---|---|
| 8 | 0 | 4 | 16 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barry, AL; Jones, RN; Novick, WJ; Thornsberry, C; Wilson, HW | 1 |
1 other study(ies) available for centa and pyridine-2-azo-4-dimethylaniline cephalosporin
| Article | Year |
|---|---|
In vitro evaluation of CENTA, a new beta-lactamase-susceptible chromogenic cephalosporin reagent.
Topics: Bacteriological Techniques; beta-Lactamase Inhibitors; beta-Lactamases; Cephalosporins; Citrobacter; Drug Evaluation, Preclinical; Enterobacteriaceae; Escherichia coli; Evaluation Studies as Topic; Indicators and Reagents; Klebsiella; Proteus mirabilis | 1982 |